Orencia

Active Ingredient(s): Abatacept
FDA Approved: * December 23, 2005
Pharm Company: * BRISTOL MYERS SQUIBB
Category: Arthritis

Abatacept, sold under the brand name Orencia, is a medication used to treat autoimmune diseases like rheumatoid arthritis, by interfering with the immune activity of T cells.[1][3] It is a modified antibody.[1][3] Abatacept is a fusion protein composed of the Fc region of the immunoglobulin IgG1 fused to the extracellular domain of CTLA-4. In order for a T cell to be activated and produce an immune response, an antigen-presenting... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Orencia 250 mg/15ml Intravenous Injection, Powder, Lyophilized, for Solution

NDC: 0003-2187

Labeler:

E.r. Squibb & Sons, L.L.C.

Orencia 125 mg/ml Subcutaneous Injection, Solution

NDC: 0003-2188

Labeler:

E.r. Squibb & Sons, L.L.C.

Orencia 50 mg/.4ml Subcutaneous Injection, Solution

NDC: 0003-2814

Labeler:

E.r. Squibb & Sons, L.L.C.

Orencia 87.5 mg/.7ml Subcutaneous Injection, Solution

NDC: 0003-2818

Labeler:

E.r. Squibb & Sons, L.L.C.

Dosage List

Popular Topics